Department of Pharmacology, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad, Pakistan.
Department of Pharmacology, University College of Pharmacy, University of the Punjab, Lahore, Pakistan.
Inflammopharmacology. 2020 Feb;28(1):139-151. doi: 10.1007/s10787-019-00596-3. Epub 2019 Apr 29.
Moringa rivae is widely used as a traditional remedy against arthritis. The present research was designed to evaluate the anti-arthritic potential of Moringa rivae extracts. Treatment of rats with adjuvant-induced arthritis with methanolic and aqueous extracts of M. rivae (150, 300 or 600 mg/kg), and piroxicam (10 mg/kg) was started orally at day 8 post-administration of complete Freund's adjuvant and continued till 28th day. The therapeutic effect of the plant extracts was assessed in arthritic rats by arthritic index, body weight, and haematological and biochemical parameters. Furthermore, the modulatory effect on gene expression (I-κB, IL-4 and IL-10, COX-2, IL-1β and IL-6, NF-κB, and TNF-α) in the blood was determined using qRT-PCR, while ELISA assay was used to find PGE2 and TNF-α concentrations in the serum. Oxidative stress parameters in the liver and ankle joint histopathology were also evaluated. Moreover, the most effective methanolic extract was further characterized by GC-MS for the presence of phytochemicals. Treatment with the plant extracts significantly restored arthritic index, change in the body weight and immune organ weight, and the histopathological indices. Both extracts significantly (p < 0.05) reduced the serum concentration of rheumatoid factor, C-reactive protein, PGE2, and TNF-α in arthritic rats. The extracts persuasively down-regulated the COX-2, PGE2, IL-1β, IL-6, NF-κB, and TNF-α, and up-regulated the mRNA expression of I-κB, IL-4, and IL-10. Both extracts increased the activities of CAT and SOD while reducing the formation of MDA in a dose- dependent manner in the liver. Histopathological evaluation showed that treatment with the plant extracts significantly (p < 0.05) reduced joint inflammation, pannus formation, and bone erosion in treatment groups in comparison to arthritic control. Phytochemicals detected by GC-MS in the methanolic extract included esters, alcohols, ketones, fatty acids, and vitamin E. These findings provide evidence of the anti-arthritic potential of M. rivae extracts in chronic polyarthritis model.
辣木树被广泛用作治疗关节炎的传统药物。本研究旨在评估辣木树提取物的抗关节炎潜力。在完全弗氏佐剂给药后第 8 天开始,通过口服给予关节炎大鼠辣木树(150、300 或 600mg/kg)的甲醇和水提取物以及吡罗昔康(10mg/kg),并持续至第 28 天。通过关节炎指数、体重以及血液学和生物化学参数评估植物提取物对关节炎大鼠的治疗效果。此外,使用 qRT-PCR 确定对血液中基因表达(I-κB、IL-4 和 IL-10、COX-2、IL-1β 和 IL-6、NF-κB 和 TNF-α)的调节作用,同时使用 ELISA 测定法测定血清中 PGE2 和 TNF-α的浓度。还评估了肝脏中的氧化应激参数和踝关节组织病理学。此外,通过 GC-MS 进一步对最有效的甲醇提取物进行特征描述,以确定植物化学物质的存在。植物提取物的治疗显著恢复了关节炎指数、体重和免疫器官重量以及组织病理学指数。两种提取物均显著(p<0.05)降低了关节炎大鼠血清中类风湿因子、C 反应蛋白、PGE2 和 TNF-α的浓度。提取物有力地下调了 COX-2、PGE2、IL-1β、IL-6、NF-κB 和 TNF-α,并上调了 I-κB、IL-4 和 IL-10 的 mRNA 表达。两种提取物均以剂量依赖的方式增加了 CAT 和 SOD 的活性,同时减少了 MDA 的形成。组织病理学评价表明,与关节炎对照组相比,植物提取物治疗组显著(p<0.05)减少了关节炎症、血管翳形成和骨侵蚀。GC-MS 检测到的甲醇提取物中的植物化学物质包括酯类、醇类、酮类、脂肪酸和维生素 E。这些发现为辣木树提取物在慢性多关节炎模型中的抗关节炎潜力提供了证据。